Skip to main content

Matt Tegowski (Al Baldwin lab) published a paper titled “Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2s in Journal of Biological Chemistry (DOI: 10.1074/jbc.RA118.003719). Image: Model describing mechanism of thioridazine effects on triple-negative breast cancer cell lines; see article for details.

Please see our page on Publications by GMB Students for more.

Comments are closed.